Disclosures: Alexandra McCullough: Nothing to Disclose, Marina Serper: Transplant Genomics: Grant/Research Support, Grifols: Grant/Research Support, Eurofins: Grant/Research Support, David Kaplan: AstraZeneca Inc: Grant/Research Support, Roche Genentech: Independent Contractor, Exact Sciences: Grant/Research Support, Glycotest: Grant/Research Support, Sirtex: Advisor, Exelixis: Advisor, AstraZeneca: Advisor, Nadim Mahmud: Nothing to Disclose 2203 THE ASSOCIATION BETWEEN ALBUMIN ADMINISTRATION AND ACUTE KIDNEY INJURY OUTCOMES IN PATIENTS HOSPITALIZED WITH SPONTANEOUS BACTERIAL PERITONITIS Marina Serper 1 Alexandra McCullough 2 David Kaplan 3 Nadim Mahmud 2 , 1 University of Pennsylvania Health System, 2 Hospital of the University of Pennsylvania, 3 University of Pennsylvania Background: Patients who have cirrhosis decompensated by ascites are at risk for spontaneous bacterial peritonitis (SBP)

Green offers a host of treatment options for various forms of facial and bodily hyperpigmentation, helping patients of every skin tone and skin type achieve a brighter, clearer, more even skin tone that lasts
2 oz Formula: Provides 30 days of support when administered at the standard dose (6 sprays, twice daily)
Preparation of submicron liposomes exhibiting efficient entrapment of drugs by freeze-drying water-in-oil emulsions
It can curtail the transcription of SLC7A11, influencing System Xc-'s activity [65]